October 2, 2017
News
September 26, 2017
Watch our webinar titled “How Changes to the Patented Medicine Prices Review Board Could Affect Patients’ Access to Drugs”
Read More
September 22, 2017
New First Line Treatment Now Available for Canadians with Metastatic Non-Small Cell Lung Cancer
Read More
September 21, 2017
First-in-class BRCA-positive Ovarian Cancer Medicine Lynparza® (olaparib) Receives Positive pan-Canadian Oncology Drug Review (pCODR) Recommendation for Provincial Reimbursement
Read More
September 14, 2017
Cancer-Associated Thrombosis: A Critical Gap in Cancer Care
Read More
September 13, 2017
Registration Now Open for the Second Annual Drug Pricing Policy Summit
Read More
September 11, 2017
Saskatchewan latest province to help protect boys from cancer with HPV vaccine
Read More
September 8, 2017
pCODR gives initial positive recommendation for Ovarian Cancer Drug
Read More
September 5, 2017
Do You have Metastatic Prostate Cancer?
Read More
August 31, 2017